CALA management, unfortunately subpar 2.1 | CALA Message Board Posts

Calithera Biosciences, Inc.

  CALA website


    30% off entry-level Bronze Patron packages (retails for $250 - reduced to $175)
    includes 2 yrs of Premium Plus service & locks in 30% discount for any future Patron upgrades

    Only 35 spots available (first come, first served)

    BONUS: Purchase your spot over the next 24 hrs & get an extra year of Premium Plus service absolutely free! 

    CLICK HERE to become a Bronze Patron now 

CALA   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  2685 of 2755  at  7/2/2019 5:24:24 PM  by


 In response to msg 2684 by  logansdad
view thread

Re: CALA management, unfortunately subpar 2.1

"Setting aside the management discussion, below is what's interesting about the science."

Great post, logansdad, and worthy of it's own thread.
In the future, I for one, would really appreciate if you would post anew with such information - makes it mush easier to find if backtracking. In addition to your update on the science, there are a couple of foreign studies posted to Pubmed's NCBI database revealing the current academic interest in CB-839 for its extraordinary effect on glutamine to proline conversion. Looking beyond glutaminase treatment in oncology, this research enables the potential for applications in diabetes and other metabolic disorders.

     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 3     Views: 387
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 All rights reserved. User Agreement
Financial Market Data provided by